OTCMKTS:ARTH

Arch Therapeutics News Headlines

$0.10
-0.01 (-6.71 %)
(As of 09/17/2021 03:53 PM ET)
Add
Compare
Today's Range
$0.09
$0.10
50-Day Range
$0.06
$0.13
52-Week Range
$0.06
$0.20
Volume308,600 shs
Average Volume485,672 shs
Market Capitalization$22.73 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.29

Media Mentions By Week

Arch Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARTH
News Sentiment

0.66

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARTH Articles
This Week

3

0

ARTH Articles
Average Week

Get Arch Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTH and its competitors with MarketBeat's FREE daily newsletter.

Arch Therapeutics (OTCMKTS ARTH) News Headlines Today

SourceHeadline
Arch Therapeutics, Inc. (OTCMKTS:ARTH) Short Interest Down 86.4% in AugustArch Therapeutics, Inc. (OTCMKTS:ARTH) Short Interest Down 86.4% in August
americanbankingnews.com - September 14 at 3:16 PM
Arch Therapeutics (OTCMKTS:ARTH) vs. Cytosorbents (NASDAQ:CTSO) Financial ReviewArch Therapeutics (OTCMKTS:ARTH) vs. Cytosorbents (NASDAQ:CTSO) Financial Review
americanbankingnews.com - September 13 at 7:12 PM
Arch Therapeutics (OTCMKTS:ARTH) Stock Price Up 15.6%Arch Therapeutics (OTCMKTS:ARTH) Stock Price Up 15.6%
americanbankingnews.com - September 4 at 1:01 AM
Arch Therapeutics Partners with Lovell Government Services to Expand Distribution CapabilitiesArch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities
ca.finance.yahoo.com - September 2 at 7:18 AM
Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of SalesArch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sales
finance.yahoo.com - July 12 at 8:42 AM
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021
finance.yahoo.com - July 7 at 12:41 PM
Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021
finance.yahoo.com - June 2 at 9:15 AM
Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS)Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS)
finance.yahoo.com - May 10 at 8:08 AM
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial OfficerArch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
finance.yahoo.com - May 3 at 8:38 AM
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)
finance.yahoo.com - April 27 at 8:06 AM
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical ResultsArch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
finance.yahoo.com - April 19 at 9:55 AM
Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021
finance.yahoo.com - March 2 at 12:55 PM
Arch Therapeutics Announces Closing of $6.9 Million Private PlacementArch Therapeutics Announces Closing of $6.9 Million Private Placement
finance.yahoo.com - February 18 at 8:19 AM
Arch Therapeutics Inc.Arch Therapeutics Inc.
barrons.com - December 17 at 8:33 PM
Arch raises capital via convertible note issuanceArch raises capital via convertible note issuance
seekingalpha.com - November 10 at 10:24 AM
Arch Therapeutics’ AC5 Advanced Wound System Presented at the 2020 Symposium on Advanced Wound Care (SAWC) FallArch Therapeutics’ AC5 Advanced Wound System Presented at the 2020 Symposium on Advanced Wound Care (SAWC) Fall
finance.yahoo.com - November 9 at 8:27 AM
Arch Therapeutics Inc. Register (A47.SG)Arch Therapeutics Inc. Register (A47.SG)
au.finance.yahoo.com - October 10 at 8:28 AM
Arch Therapeutics IncArch Therapeutics Inc
bloomberg.com - October 2 at 2:55 PM
Arch Therapeutics AC5 Heals Recalcitrant Diabetic Foot UlcerArch Therapeutics' AC5 Heals Recalcitrant Diabetic Foot Ulcer
seekingalpha.com - September 22 at 10:32 PM
With FDA and EU Marketing Authorizations in Hand, 2020 and 2021 Can Be Catalyst Years for Arch TherapeuticsWith FDA and EU Marketing Authorizations in Hand, 2020 and 2021 Can Be Catalyst Years for Arch Therapeutics
finance.yahoo.com - September 22 at 12:31 PM
Arch Therapeutics, Inc. (ARTH)Arch Therapeutics, Inc. (ARTH)
in.finance.yahoo.com - September 16 at 8:23 PM
Arch Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15 at 12 PM ETArch Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15 at 12 PM ET
finance.yahoo.com - September 10 at 8:27 AM
ARCH THERAPEUTICS DL-,001 (A47.BE)ARCH THERAPEUTICS DL-,001 (A47.BE)
au.finance.yahoo.com - August 26 at 10:59 PM
Arch Therapeutics to Present at The LD 500 Virtual Conference on Tuesday, September 1 at 1 PM ETArch Therapeutics to Present at The LD 500 Virtual Conference on Tuesday, September 1 at 1 PM ET
finance.yahoo.com - August 26 at 7:58 AM
Arch Therapeutics Novel Self-Assembling Agent, AC5-GTM, for Use in Endoscopic Procedures was Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual MeetingArch Therapeutics Novel Self-Assembling Agent, AC5-GTM, for Use in Endoscopic Procedures was Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting
finance.yahoo.com - August 11 at 4:39 PM
Arch Therapeutics announces capital raise of $1.4MArch Therapeutics announces capital raise of $1.4M
seekingalpha.com - June 8 at 1:47 PM
Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization StudyArch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study
www.bloomberg.com - June 2 at 6:04 AM
Arch Therapeutics Provides Corporate Milestone Update, Including Anticipated Filing of 510(k) for AC5(TM)Arch Therapeutics Provides Corporate Milestone Update, Including Anticipated Filing of 510(k) for AC5(TM)
www.bloomberg.com - May 14 at 7:47 PM
Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5
www.bloomberg.com - May 14 at 7:47 PM
Arch Therapeutics Receives Marketing Clearance from the US FDA Related to the AC5® Topical Gel Supply ChainArch Therapeutics Receives Marketing Clearance from the US FDA Related to the AC5® Topical Gel Supply Chain
finance.yahoo.com - March 23 at 7:57 AM
Arch Therapeutics, Inc. to Present at the New York City based Investor Summit on March 25th-26thArch Therapeutics, Inc. to Present at the New York City based Investor Summit on March 25th-26th
finance.yahoo.com - March 18 at 12:46 PM
Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting on April 2, 2020Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting on April 2, 2020
finance.yahoo.com - March 4 at 9:13 AM
Arch Therapeutics Inc (ARTH) Option ChainArch Therapeutics Inc (ARTH) Option Chain
www.nasdaq.com - February 12 at 6:44 PM
Arch Therapeutics Inc (ARTH) Real-Time QuotesArch Therapeutics Inc (ARTH) Real-Time Quotes
www.nasdaq.com - February 12 at 6:44 PM
Student Information System Market Research Report, Upcoming Trends, Demand, Regional Analysis and Forecast 2024Student Information System Market Research Report, Upcoming Trends, Demand, Regional Analysis and Forecast 2024
www.marketwatch.com - February 5 at 2:40 PM
Arch Therapeutics (ARTH) Presents At Biotech Showcase 2020 - SlideshowArch Therapeutics (ARTH) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 14 at 10:08 PM
Arch Therapeutics to Provide Corporate Update at Biotech Showcase™ 2020 on January 13th, 2020Arch Therapeutics to Provide Corporate Update at Biotech Showcase™ 2020 on January 13th, 2020
finance.yahoo.com - January 8 at 4:55 PM
Arch Therapeutics Receives Recommendation That CE Mark Be GrantedArch Therapeutics Receives Recommendation That CE Mark Be Granted
seekingalpha.com - November 21 at 7:33 PM
Arch Therapeutics Inc (ARTH) Advanced ChartingArch Therapeutics Inc (ARTH) Advanced Charting
www.nasdaq.com - November 7 at 5:06 PM
Arch Therapeutics launches $2.5M registered direct offeringArch Therapeutics launches $2.5M registered direct offering
seekingalpha.com - October 17 at 12:22 PM
Arch Therapeutics Announces $2.5 Million Registered Direct OfferingArch Therapeutics Announces $2.5 Million Registered Direct Offering
finance.yahoo.com - October 17 at 12:22 PM
Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NYArch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
finance.yahoo.com - October 7 at 2:27 PM
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment ConferenceArch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 3 at 8:36 AM
Arch Therapeutics in the green as AC5 nears CE Mark certificationArch Therapeutics in the green as AC5 nears CE Mark certification
seekingalpha.com - August 5 at 11:47 PM
Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical HemostatArch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat
finance.yahoo.com - August 5 at 8:52 AM
Arch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro InvitationalArch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro Invitational
finance.yahoo.com - May 30 at 8:22 AM
Arch Therapeutics prices $2.8M registered direct offeringArch Therapeutics prices $2.8M registered direct offering
seekingalpha.com - May 13 at 7:59 PM
Arch Therapeutics, Inc. $2.8 Million Registered Direct OfferingArch Therapeutics, Inc. $2.8 Million Registered Direct Offering
finance.yahoo.com - May 13 at 8:12 AM
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel VideoArch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
finance.yahoo.com - April 24 at 8:16 AM
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH ConferenceArch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference
finance.yahoo.com - March 11 at 7:47 PM
Get Arch Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTH and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.